Kirkland & Ellis and Zhong Lun advised Yunkang Group Limited on the deal. Herbert Smith Freehills advised CMB International Capital Limited and SPDB International Capital Limited....
Yunkang Group Limited’s $140 Million Hong Kong Listing
Recbio Technology Co., Ltd.’s US$98 Million Initial Public Offering
Kirkland & Ellis advised Jiangsu Recbio Technology Co., Ltd., while Clifford Chance has advised the joint sponsors and underwriters involved in the deal. Recbio Technology Co.,...
Arrail Group Limited’s US$88 Million Initial Public Offering
Harneys acted as British Virgin Islands and Cayman Islands counsel for the successful listing of the shares of Arrail Group Limited on the Main Board of...
CANbridge Pharmaceuticals Inc.’s HK$604 Million IPO
Harneys, alongside Davis Polk & Wardwell and King & Wood Mallesons, acted as Cayman Islands counsel to CANbridge Pharmaceuticals Inc. Kirkland & Ellis and Tian Yuan...
Haidilao’s $300 Million Share Placement
Kirkland & Ellis advised Haidilao International Holding on the deal. Haidilao International Holding Ltd. (HKSE: 6862), a leading Chinese hotpot restaurant chain, announced the raising of...
Airdoc Technology’s $215 Million Initial Public Offering
Kirkland & Ellis advised Beijing Airdoc Technology Co., Ltd on the offering. Airdoc, raised approximately $215 million in the IPO, received strong endorsement from blue-chip investors...
Clover Biopharmaceuticals’ US$257.8 Million Hong Kong Initial Public Offering
Skadden advised Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited and Credit Suisse (Hong Kong) Limited as lead underwriters on the IPO....
Li Auto’s HKD11.8 Billion Hong Kong Dual Primary Listing
King & Wood Mallesons and Kirkland advised the joint sponsors and underwriters on Li Auto Inc.’s listing. Skadden advised Li Auto Inc. On 12 August 2021,...
Keymed Biosciences’ US$400 Million Hong Kong IPO
O’Melveny & Myers and Cooley LLP advised Keymed Biosciences Inc. on the deal, while Kirkland & Ellis advised the joint sponsors and underwriters. Keymed Biosciences Inc....
Nayuki’s $655 Million Initial Public Offering
Kirkland & Ellis advised the sponsors and underwriters on the initial public offering of Nayuki Holdings Limited, assisted by Walkers and Davis Polk & Wardwell. Other...
Airdoc’s Series D Financing Round
Kirkland & Ellis advised Beijing Airdoc Technology Co., Ltd. on the deal. Beijing Airdoc Technology Co., Ltd., a global market leader and pioneer in providing AI-empowered...
EDDA Healthcare and Technology’s $150 Million Financing Round
Kirkland & Ellis advised EDDA Healthcare and Technology Holding Limited on the deal, while Zhong Lun Law Firm Assisted SoftBank Vision Fund II. EDDA Healthcare and...